| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 72 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64 |
| Body Types | Overweight, Average |
No significant effects of 750mg steviosides daily for 3 months aside from a small reduction in blood pressure and glucose seen in the type 1 diabetic cohort.
